Henry ScheinHSIC
HSIC
About: Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
Employees: 25,000
0
Funds holding %
of 7,407 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
216% more call options, than puts
Call options by funds: $13.8M | Put options by funds: $4.37M
42% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 50
25% more funds holding in top 10
Funds holding in top 10: 8 [Q3] → 10 (+2) [Q4]
2% more funds holding
Funds holding: 523 [Q3] → 535 (+12) [Q4]
1.11% more ownership
Funds ownership: 101.5% [Q3] → 102.61% (+1.11%) [Q4]
6% less capital invested
Capital invested by funds: $9.37B [Q3] → $8.86B (-$516M) [Q4]
16% less repeat investments, than reductions
Existing positions increased: 173 | Existing positions reduced: 207
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$80
24%
upside
Avg. target
$83
27%
upside
High target
$90
39%
upside
4 analyst ratings
1 positive
25%
3 neutral
75%
0 negative
0%
UBS Kevin Caliendo 57% 1-year accuracy 8 / 14 met price target | 24%upside $80 | Neutral Maintained | 26 Feb 2025 |
Barrington Research Michael Petusky 19% 1-year accuracy 13 / 69 met price target | 39%upside $90 | Outperform Maintained | 26 Feb 2025 |
Wells Fargo Vik Chopra 36% 1-year accuracy 4 / 11 met price target | 24%upside $80 | Equal-Weight Initiated | 14 Feb 2025 |
Jefferies Brandon Couillard 24% 1-year accuracy 6 / 25 met price target | 24%upside $80 | Hold Maintained | 23 Jan 2025 |
Financial journalist opinion
Based on 5 articles about HSIC published over the past 30 days
Neutral
Business Wire
1 week ago
Henry Schein to Webcast First Quarter 2025 Conference Call on Monday, May 5th, 2025, at 8:00 a.m. ET
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its first quarter 2025 financial results before the stock market opens on Monday, May 5th, 2025, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board.
Neutral
Business Wire
1 week ago
Henry Schein Received Validation of Net-Zero Science-Based Targets
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Science Based Targets initiative (SBTi) has approved the Company's near-term and long-term science-based emissions reduction targets and has verified Henry Schein's net-zero science-based target by 2050. “Having joined the Business Ambition for 1.5⁰C initiative in 2021, Henry Schein is pleased to fulf.
Neutral
Business Wire
2 weeks ago
IntelePeer Joins Henry Schein One API Exchange as an Authorized Integration Vendor
DANIA BEACH, Fla.--(BUSINESS WIRE)--IntelePeer, the leading end-to-end conversational AI platform provider, is now an authorized integration vendor in the Henry Schein One API Exchange, allowing dental practice teams to easily use IntelePeer's SmartAgent and SmartOffice solutions. Offering highly personalized and timely patient interactions, these solutions utilize reliable, scalable AI agents that automate inbound and outbound patient calls and provide self-service options, guaranteeing effici.
Negative
Zacks Investment Research
3 weeks ago
Why Is Henry Schein (HSIC) Down 3.9% Since Last Earnings Report?
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
Neutral
Business Wire
3 weeks ago
Henry Schein Will Showcase a Selection of the Company's Comprehensive Solutions for Oral Health Professionals at the 2025 International Dental Show
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) will showcase a selection of its comprehensive business and practice solutions, and provide perspectives on the future of dentistry, during the 2025 International Dental Show (IDS) in Cologne, Germany, from March 25 to 29, 2025, at the Koelnmesse in Hall 4.1, Stand A-090 and A-008. Media roundtable sessions At Koelnmesse, Henry Schein will present “Conversations with Henry Schein: Exploring the Present and Future of Oral Health,.
Neutral
Business Wire
1 month ago
Ethisphere Names Henry Schein as One of the 2025 World's Most Ethical Companies® for 14th Consecutive Year
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, has received the 2025 World's Most Ethical Companies® recognition by Ethisphere, a global leader in defining and advancing the standards of ethical business practices. Recognized since 2012, Henry Schein is one of three honorees in the Healthcare Products industry. In 2025, 136 honorees were recognized, spanning 19 countries.
Positive
Seeking Alpha
1 month ago
Henry Schein Looks Bullish (Technical Analysis)
HSIC shows bullish price action, momentum, volume, and relative strength, making it an attractive investment with a 2.6 reward-to-risk ratio. The stock is in an uptrend, trading above its 30-week EMA, and has bullish short-term and long-term momentum as indicated by the PPO. Institutional buying supports bullish volume trends, and HSIC has been outperforming the S&P 500 since December 2024.
Positive
Seeking Alpha
1 month ago
Henry Schein: An Industry Leader That Offers Some Upside From Here
Henry Schein is the world's largest provider of healthcare products and services for office-based dental and medical practitioners, showing consistent growth through acquisitions. Despite a 3% dip in shares, management's 2025 guidance indicates continued growth, justifying a bullish stance on the stock. The firm reported a 5.8% revenue increase in Q4 2024, driven by organic growth and acquisitions, with significant improvements in net income and operating cash flow.
Neutral
Business Wire
1 month ago
Henry Schein to Participate in Upcoming Investor Conference in March
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the Leerink Global Healthcare Conference on Tuesday, March 11th, 2025, at the W South Beach hotel in Miami at 1:40 p.m. Eastern time. Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Sc.
Neutral
Business Wire
1 month ago
Nominations Now Open for Henry Schein Medical's Athletics and Schools 2025 Rising Star Award
MELVILLE, N.Y.--(BUSINESS WIRE)--In celebration of National Athletic Training Month in March, Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is now accepting nominations for its Henry Schein Medical Athletics and Schools 2025 Rising Star Award. Created in 2021, the annual Award honors emerging athletic trainers who have one to five years of experience in the sports medicine profession. It recognizes recently graduated athletic trainers in the United States.
Charts implemented using Lightweight Charts™